 | XKN | Name: | 3-ethynyl-5-{[(3R)-4-{1-[(2-methoxyphenyl)methyl]-1H-benzimidazole-5-carbonyl}-3-methylpiperazin-1-yl]methyl}benzene-1-sulfonyl fluoride | Formula: | C30 H29 F N4 O4 S | SMILES: | COc1ccccc1Cn1cnc2cc(ccc12)C(=O)N1CCN(Cc2cc(cc(C#C)c2)S(F)(=O)=O)CC1C | InChi: | InChI=1S/C30H29FN4O4S/c1-4-22-13-23(15-26(14-22)40(31,37)38)18-33-11-12-35(21(2)17-33)30(36)24-9-10-28-27(16-24)32-20-34(28)19-25-7-5-6-8-29(25)39-3/h1,5-10,13-16,20-21H,11-12,17-19H2,2-3H3/t21-/m1/s1 | Definition date: | 2022-11-23 | Last modified: | 2024-09-27 | Release date: | 2023-05-31 | Identifier: | 3-ethynyl-5-{[(3R)-4-{1-[(2-methoxyphenyl)methyl]-1H-benzimidazole-5-carbonyl}-3-methylpiperazin-1-yl]methyl}benzene-1-sulfonyl fluoride |
|
 | SA1 | Name: | (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE | Formula: | C15 H21 N O4 | SMILES: | O=C1NC(C=O)(C2(OCCC12)C)C(O)C3C=CCCC3 | InChi: | InChI=1S/C15H21NO4/c1-14-11(7-8-20-14)13(19)16-15(14,9-17)12(18)10-5-3-2-4-6-10/h3,5,9-12,18H,2,4,6-8H2,1H3,(H,16,19)/t10-,11+,12+,14+,15-/m1/s1 | Synonyms: | Salinosporamide A, bound form | Definition date: | 2005-12-29 | Last modified: | 2024-09-27 | Identifier: | (3aR,6R,6aS)-6-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-6a-methyl-4-oxohexahydro-2H-furo[2,3-c]pyrrole-6-carbaldehyde |
|
 | WRP | Name: | (betaR)-beta-hydroxy-1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-L-tryptophan | Formula: | C16 H22 N2 O4 | SMILES: | O=C(O)C(N)C(O)c2c1ccccc1n(c2)C(C)(C)C(O)C | InChi: | InChI=1S/C16H22N2O4/c1-9(19)16(2,3)18-8-11(14(20)13(17)15(21)22)10-6-4-5-7-12(10)18/h4-9,13-14,19-20H,17H2,1-3H3,(H,21,22)/t9-,13+,14-/m1/s1 | Definition date: | 2013-06-20 | Last modified: | 2024-09-27 | Release date: | 2013-09-18 | Identifier: | (betaR)-beta-hydroxy-1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-L-tryptophan |
|
 | XZK | Name: | N-(4-carbamoylphenyl)-2-chloro-5-nitrobenzamide | Formula: | C14 H10 Cl N3 O4 | SMILES: | O=C(Nc1ccc(cc1)C(N)=O)c1cc(ccc1Cl)[N+]([O-])=O | InChi: | InChI=1S/C14H10ClN3O4/c15-12-6-5-10(18(21)22)7-11(12)14(20)17-9-3-1-8(2-4-9)13(16)19/h1-7H,(H2,16,19)(H,17,20) | Definition date: | 2022-12-15 | Last modified: | 2024-09-27 | Release date: | 2024-03-20 | Identifier: | N-(4-carbamoylphenyl)-2-chloro-5-nitrobenzamide |
|
 | T3G | Name: | 1-{4-[(2,6-difluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one | Formula: | C12 H14 F2 N2 O3 S | SMILES: | N2(CCN(S(c1c(cccc1F)F)(=O)=O)CC2)C(=O)C | InChi: | InChI=1S/C12H14F2N2O3S/c1-9(17)15-5-7-16(8-6-15)20(18,19)12-10(13)3-2-4-11(12)14/h2-4H,5-8H2,1H3 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-{4-[(2,6-difluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one |
|
 | SA2 | Name: | (3R)-4-[(4-CARBOXYBUTANOYL)OXY]-N-[(1E)-3-OXOPROP-1-EN-1-YL]-3-SULFINO-D-VALINE | Formula: | C13 H19 N O9 S | SMILES: | O=C(OCC(S(=O)O)(C(C(=O)O)NC=CC=O)C)CCCC(=O)O | InChi: | InChI=1S/C13H19NO9S/c1-13(24(21)22,11(12(19)20)14-6-3-7-15)8-23-10(18)5-2-4-9(16)17/h3,6-7,11,14H,2,4-5,8H2,1H3,(H,16,17)(H,19,20)(H,21,22)/b6-3+/t11-,13-/m0/s1 | Synonyms: | 4-AZA-5-CARBOXY-6-SULFENATE-6-METHYL-8-OXA-9-OXO-TRIS-2-TRANS-DECENEDIOIC ACID | Definition date: | 2006-06-09 | Last modified: | 2024-09-27 | Identifier: | (3R)-4-[(4-carboxybutanoyl)oxy]-N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine |
|
 | ZAB | Name: | (3-{(Z)-[3-(AMINOMETHYL)PHENYL]DIAZENYL}PHENYL)ACETIC ACID | Formula: | C15 H15 N3 O2 | SMILES: | O=C(O)Cc2cccc(N=N/c1cccc(c1)CN)c2 | InChi: | InChI=1S/C15H15N3O2/c16-10-12-4-2-6-14(8-12)18-17-13-5-1-3-11(7-13)9-15(19)20/h1-8H,9-10,16H2,(H,19,20)/b18-17- | Definition date: | 2006-06-01 | Last modified: | 2024-09-27 | Identifier: | (3-{(Z)-[3-(aminomethyl)phenyl]diazenyl}phenyl)acetic acid |
|
 | XKQ | Name: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S)-6,6-difluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | Formula: | C24 H40 F2 N4 O6 | SMILES: | CNC(=O)C(O)C(CCC(C)(F)F)NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)OC)C(C)(C)C | InChi: | InChI=1S/C24H40F2N4O6/c1-23(2,3)18(29-22(35)36-6)21(34)30-12-13-8-7-9-14(13)16(30)19(32)28-15(10-11-24(4,25)26)17(31)20(33)27-5/h13-18,31H,7-12H2,1-6H3,(H,27,33)(H,28,32)(H,29,35)/t13-,14-,15-,16-,17+,18+/m0/s1 | Definition date: | 2023-11-03 | Last modified: | 2024-09-27 | Release date: | 2024-03-06 | Identifier: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S)-6,6-difluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate (non-preferred name) |
|
 | SA6 | Name: | (2R,3S,4R)-2-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-ethyl-3-hydroxy-3-methyl-5-oxopyrrolidine-2-carbaldehyde | Formula: | C15 H23 N O4 | SMILES: | O=CC1(NC(=O)C(C1(O)C)CC)C(O)C2C=CCCC2 | InChi: | InChI=1S/C15H23NO4/c1-3-11-13(19)16-15(9-17,14(11,2)20)12(18)10-7-5-4-6-8-10/h5,7,9-12,18,20H,3-4,6,8H2,1-2H3,(H,16,19)/t10-,11+,12+,14+,15-/m1/s1 | Definition date: | 2010-04-20 | Last modified: | 2024-09-27 | Identifier: | (2R,3S,4R)-2-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-ethyl-3-hydroxy-3-methyl-5-oxopyrrolidine-2-carbaldehyde |
|
 | M6L | Name: | (phenylmethyl) ~{N}-[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S},3~{S})-2-oxidanyl-1-oxidanylidene-1-(pyridin-2-ylmethylamino)hexan-3-yl]amino]pentan-2-yl]carbamate | Formula: | C26 H36 N4 O5 | SMILES: | CCC[CH](NC(=O)[CH](CC(C)C)NC(=O)OCc1ccccc1)[CH](O)C(=O)NCc2ccccn2 | InChi: | InChI=1S/C26H36N4O5/c1-4-10-21(23(31)25(33)28-16-20-13-8-9-14-27-20)29-24(32)22(15-18(2)3)30-26(34)35-17-19-11-6-5-7-12-19/h5-9,11-14,18,21-23,31H,4,10,15-17H2,1-3H3,(H,28,33)(H,29,32)(H,30,34)/t21-,22-,23-/m0/s1 | Definition date: | 2022-07-25 | Last modified: | 2024-09-27 | Release date: | 2023-08-02 | Identifier: | (phenylmethyl) ~{N}-[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S},3~{S})-2-oxidanyl-1-oxidanylidene-1-(pyridin-2-ylmethylamino)hexan-3-yl]amino]pentan-2-yl]carbamate |
|
 | NSN | Name: | N~2~-(2-AMINO-1-METHYL-2-OXOETHYLIDENE)ASPARAGINATE | Formula: | C7 H11 N3 O4 | SMILES: | [O-]C(=O)CC(/[NH+]=C(/C(=O)N)C)C(=O)N | InChi: | InChI=1S/C7H11N3O4/c1-3(6(8)13)10-4(7(9)14)2-5(11)12/h4H,2H2,1H3,(H2,8,13)(H2,9,14)(H,11,12)/b10-3+/t4-/m0/s1 | Definition date: | 2003-07-07 | Last modified: | 2024-09-27 | Identifier: | (3S)-4-amino-3-{[(1E)-2-amino-1-methyl-2-oxoethylidene]ammonio}-4-oxobutanoate |
|
 | ONH | Name: | N~5~-hydroxy-L-ornithine | Formula: | C5 H12 N2 O3 | SMILES: | O=C(O)C(N)CCCNO | InChi: | InChI=1S/C5H12N2O3/c6-4(5(8)9)2-1-3-7-10/h4,7,10H,1-3,6H2,(H,8,9)/t4-/m0/s1 | Definition date: | 2011-06-02 | Last modified: | 2024-09-27 | Identifier: | N~5~-hydroxy-L-ornithine |
|
 | T3J | Name: | 1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one | Formula: | C12 H14 F N O2 | SMILES: | c1(ccc(F)cc1)C2CN(C(C)=O)CCO2 | InChi: | InChI=1S/C12H14FNO2/c1-9(15)14-6-7-16-12(8-14)10-2-4-11(13)5-3-10/h2-5,12H,6-8H2,1H3/t12-/m0/s1 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one |
|
 | ZAE | Name: | N-methyl-D-phenylalanine | Formula: | C10 H13 N O2 | SMILES: | O=C(O)C(NC)Cc1ccccc1 | InChi: | InChI=1S/C10H13NO2/c1-11-9(10(12)13)7-8-5-3-2-4-6-8/h2-6,9,11H,7H2,1H3,(H,12,13)/t9-/m1/s1 | Definition date: | 2009-02-06 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-phenylalanine |
|
 | ZT1 | Name: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine | Formula: | C14 H26 N4 O2 | SMILES: | Cn1cncc1CN(CCCCC(N)C(=O)O)C(C)C | InChi: | InChI=1S/C14H26N4O2/c1-11(2)18(9-12-8-16-10-17(12)3)7-5-4-6-13(15)14(19)20/h8,10-11,13H,4-7,9,15H2,1-3H3,(H,19,20)/t13-/m0/s1 | Definition date: | 2021-05-28 | Last modified: | 2024-09-27 | Release date: | 2021-07-21 | Identifier: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine |
|
 | NSO | Name: | ~{N}-[3-[[6-fluoranyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C28 H28 F N7 O | SMILES: | CN1CCN(CC1)c2ccc(Nc3nc(Nc4cccc(NC(=O)C=C)c4)c5cc(F)ccc5n3)cc2 | InChi: | InChI=1S/C28H28FN7O/c1-3-26(37)30-21-5-4-6-22(18-21)31-27-24-17-19(29)7-12-25(24)33-28(34-27)32-20-8-10-23(11-9-20)36-15-13-35(2)14-16-36/h3-12,17-18H,1,13-16H2,2H3,(H,30,37)(H2,31,32,33,34) | Definition date: | 2023-01-18 | Last modified: | 2024-09-27 | Release date: | 2023-08-23 | Identifier: | ~{N}-[3-[[6-fluoranyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide |
|
 | ONK | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H50 N4 O5 | SMILES: | O=C(NC(CC(C)C)C(O)C(=C)C)C(NC(=O)C(NC(=O)CCCCC)C(C)C)CCC(=O)N(C)C | InChi: | InChI=1S/C27H50N4O5/c1-10-11-12-13-22(32)30-24(18(4)5)27(36)28-20(14-15-23(33)31(8)9)26(35)29-21(16-17(2)3)25(34)19(6)7/h17-18,20-21,24-25,34H,6,10-16H2,1-5,7-9H3,(H,28,36)(H,29,35)(H,30,32)/t20-,21-,24-,25-/m0/s1 | Synonyms: | vinylketone carmaphycin analogue VNK1, single bound form | Definition date: | 2012-11-01 | Last modified: | 2024-09-27 | Release date: | 2014-01-29 | Identifier: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide |
|
 | 4J2 | Name: | (2R)-2-amino-3-(naphthalen-2-yl)propanoic acid | Formula: | C13 H13 N O2 | SMILES: | NC(Cc1ccc2ccccc2c1)C(=O)O | InChi: | InChI=1S/C13H13NO2/c14-12(13(15)16)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7,12H,8,14H2,(H,15,16)/t12-/m1/s1 | Definition date: | 2015-09-17 | Last modified: | 2024-09-27 | Release date: | 2015-12-16 | Identifier: | (2R)-2-amino-3-(naphthalen-2-yl)propanoic acid (non-preferred name) |
|
 | XZP | Name: | (1R,2R)-2-aminocyclopentane-1-carboxylic acid | Formula: | C6 H11 N O2 | SMILES: | O=C(C1CCCC1N)O | InChi: | InChI=1S/C6H11NO2/c7-5-3-1-2-4(5)6(8)9/h4-5H,1-3,7H2,(H,8,9)/t4-,5-/m1/s1 | Definition date: | 2017-05-18 | Last modified: | 2024-09-27 | Release date: | 2018-02-21 | Identifier: | (1R,2R)-2-aminocyclopentane-1-carboxylic acid |
|
 | VX | Name: | O-ETHYLMETHYLPHOSPHONIC ACID ESTER GROUP | Formula: | C3 H9 O3 P | SMILES: | O=P(O)(OCC)C | InChi: | InChI=1S/C3H9O3P/c1-3-6-7(2,4)5/h3H2,1-2H3,(H,4,5) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | ethyl hydrogen (S)-methylphosphonate |
|
 | ONL | Name: | 5-OXO-L-NORLEUCINE | Formula: | C6 H11 N O3 | SMILES: | O=C(CCC(N)C(=O)O)C | InChi: | InChI=1S/C6H11NO3/c1-4(8)2-3-5(7)6(9)10/h5H,2-3,7H2,1H3,(H,9,10)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 5-oxo-L-norleucine |
|
 | PVA | Name: | 1-AMINO-2-METHYL-PROPYLPHOSPHONIC ACID | Formula: | C4 H12 N O3 P | SMILES: | O=P(O)(O)C(N)C(C)C | InChi: | InChI=1S/C4H12NO3P/c1-3(2)4(5)9(6,7)8/h3-4H,5H2,1-2H3,(H2,6,7,8)/t4-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-amino-2-methylpropyl]phosphonic acid |
|
 | ZAI | Name: | (2~{S})-2-azanyl-6-[[(~{R})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]-[[(2~{S})-1-oxidanyl-1-oxidanylidene-3-sulfanyl-propan-2-yl]amino]methyl]amino]hexanoic acid | Formula: | C17 H29 N4 O9 P S | SMILES: | Cc1ncc(CO[P](O)(O)=O)c([CH](NCCCC[CH](N)C(O)=O)N[CH](CS)C(O)=O)c1O | InChi: | InChI=1S/C17H29N4O9PS/c1-9-14(22)13(10(6-20-9)7-30-31(27,28)29)15(21-12(8-32)17(25)26)19-5-3-2-4-11(18)16(23)24/h6,11-12,15,19,21-22,32H,2-5,7-8,18H2,1H3,(H,23,24)(H,25,26)(H2,27,28,29)/t11-,12+,15+/m0/s1 | Definition date: | 2022-07-05 | Last modified: | 2024-09-27 | Release date: | 2023-07-05 | Identifier: | (2~{S})-2-azanyl-6-[[(~{R})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]-[[(2~{S})-1-oxidanyl-1-oxidanylidene-3-sulfanyl-propan-2-yl]amino]methyl]amino]hexanoic acid |
|
 | MLE | Name: | N-METHYLLEUCINE | Formula: | C7 H15 N O2 | SMILES: | O=C(O)C(NC)CC(C)C | InChi: | InChI=1S/C7H15NO2/c1-5(2)4-6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t6-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-methyl-L-leucine |
|
 | SPM | Name: | SPERMINE | Formula: | C10 H26 N4 | SMILES: | NCCCNCCCCNCCCN | InChi: | InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N,N'-bis(3-aminopropyl)butane-1,4-diamine |
|